Research
Beneish M-Score for Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX) Beneish M-score as of Mon May 18 2026: -2.75. Full eight-component breakdown and interpretation.
Beneish M-Score for Vertex Pharmaceuticals Incorporated (VRTX)
As of 2026-05-18, Vertex Pharmaceuticals Incorporated’s Beneish M-score is -2.75.
The Beneish M-score is an eight-factor model that estimates the probability that a public company is manipulating its reported earnings. Scores above -1.78 are commonly flagged as elevated risk.
Component breakdown
| Component | Value | What it measures |
|---|---|---|
| DSRI | 0.919 | Days Sales in Receivables Index |
| GMI | 0.883 | Gross Margin Index |
| AQI | 0.86 | Asset Quality Index |
| SGI | 1.274 | Sales Growth Index |
| DEPI | 0.91 | Depreciation Index |
| SGAI | 1.111 | SG&A Index |
| TATA | -0.062 | Total Accruals to Total Assets |
| LVGI | 1.011 | Leverage Index |
How to interpret this score
See our Beneish M-score explainer for the full methodology and worked examples.